FDA Adverse Event Injury Summary report: N

STEALTHSTATION S7 PLANNING STATION

MDR report key: 6607140 · Received June 2, 2017

Report

Report Number
1723170-2017-02305
Event Type
Injury
Date Received
June 2, 2017
Date of Event
January 1, 2015
Report Date
June 1, 2017
Manufacturer
MEDTRONIC NAVIGATION, INC. (LOUISVILLE)
Product Code
HAW
UDI-DI
00613994532398
PMA / PMN Number
K050438
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

NO PATIENT IDS OR WEIGHTS WERE PROVIDED BY THE AUTHORS. LE GOFF F, DERREY S, LEFAUCHEUR R, ET AL. DECLINE IN VERBAL FLUENCY AFTER SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN PARKINSON¿S DISEASE: A MICROLESION EFFECT OF THE ELECTRODE TRAJECTORY? JOURNAL OF PARKINSON¿S DISEASE 5 (2015) 95¿104 DOI 10.3233/JPD-140443. THE EXACT SYSTEM INFORMATION COULD NOT BE DETERMINED AS IT WAS NOT PROVIDED. HOWEVER, THE SYSTEM LISTED ON THIS FORM WAS AT THE ADDRESS LISTED IN THE ARTICLE DURING THE TIME THE SURGERIES WERE COMPLETED AND HAS THE SOFTWARE INSTALLED WHICH WAS USED. NO REQUESTS FOR SYSTEM SERVICE HAVE BEEN RECEIVED REGARDING THE REPORTED EVENTS. THE ARTICLE DOES NOT ALLEGE THAT THE MEDTRONIC SYSTEM CAUSED THE REPORTED EVENTS. REPORTED EVENTS ARE KNOWN INHERENT RISKS TO THIS PROCEDURE TYPE. IT IS UP TO THE SURGEON'S DISCRETION WHERE TO PLACE THE TRAJECTORY.

Description of Event or Problem · 1

THE JOURNAL ARTICLE, DECLINE IN VERBAL FLUENCY AFTER SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN PARKINSON¿S DISEASE: A MICROLESION EFFECT OF THE ELECTRODE TRAJECTORY? BY LE GOFF ET AL, WAS REVIEWED AND IT WAS FOUND THAT ADVERSE EVENTS WERE REPORTED. MEDTRONIC FRAMELINK SOFTWARE WAS USED TO PLAN LEAD PLACEMENT. PLEASE SEE ARTICLE EXCERPTS BELOW FOR FURTHER DETAILS: "THE ARTICLE REPORTS THAT A SIGNIFICANT DECLINE OF BOTH SEMANTIC AND PHONEMIC VF (VERBAL FLUENCY) WAS FOUND AFTER SURGERY, RESPECTIVELY 14.9%±22.1 (P < 0.05) AND 14.2%±30.3 (P < 0.05). PATIENTS WHO DECLINED IN SEMANTIC VF (N = 44) HAD A LEFT TRAJECTORY WITH A MORE ANTERIOR CORTICAL ENTRY POINT (56±53 VERSUS 60±55 DEGREE, P = 0.01) PASSING LESS FREQUENTLY TROUGH THE THALAMUS (P = 0.03). CONCLUSIONS: MICROLESION OF LEFT BRAIN REGIONS MAY CONTRIBUTE TO SUBTLE COGNITIVE IMPAIRMENT FOLLOWING STN-DBS IN PD." WHILE MEDTRONIC'S FRAMELINK SOFTWARE WAS USED TO PLAN THE TRAJECTORIES. THERE IS NO INDICATION THAT THE TRAJECTORIES USED WERE ANYTHING OTHER THAN WHAT THE SURGEON INTENDED, ONLY THAT WHEN LEFT SIDED TRAJECTORIES WITH MORE ANTERIOR CORTICAL ENTRY POINTS WERE USED, THIS CORRELATED WITH DECLINE IN POSTOPERATIVE SEMANTIC VERBAL FLUENCY. MEDTRONIC NAVIGATION IS FILING THIS MDR TO ENSURE VISIBILITY TO A PATIENT EVENT AS A RESULT OF A PROCEDURE THAT UTILIZED MEDTRONIC NAVIGATION'S STEALTHSTATION NAVIGATION PLANNING SYSTEM. THERE IS NO ALLEGATION TO SUGGEST THAT MEDTRONIC NAVIGATION'S DEVICE CAUSED OR CONTRIBUTED TO THE REPORTED EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
390475 STEALTHSTATION S7 PLANNING STATION NEUROLOGICAL STEREOTAXIC INSTRUMENT HAW MEDTRONIC NAVIGATION, INC. (LOUISVILLE) S7 PLANNING STATION 00613994532398

Patients

Seq Age Sex Outcome Treatment
1 62 YR Disability